Incidence of Common Glomerular Diseases Other Than Collapsing Glomerulopathy is Not Increased After SARS-CoV-2 Infection
Kidney Int Rep
.
2024 Jan 23;9(4):1122-1126.
doi: 10.1016/j.ekir.2024.01.028.
eCollection 2024 Apr.
Authors
Matthias Diebold
1
,
Annette Enzler-Tschudy
2
,
Birgit M Helmchen
3
,
Helmut Hopfer
4
,
Min Jeong Kim
5
,
Solange Moll
6
,
Giliane Nanchen
7
,
Samuel Rotman
8
,
Harald Seeger
9
10
,
Andreas D Kistler
11
12
Affiliations
1
Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, University of Basel, Basel, Switzerland.
2
Institute of Pathology, Cantonal Hospital St. Gallen, Switzerland.
3
Institute of Pathology and Molecular Pathology, University of Zurich, Zurich, Switzerland.
4
Department of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.
5
Division of Nephrology, Cantonal Hospital Aarau, Aarau, Switzerland.
6
Service of clinical Pathology, University Hospital Geneva, University of Geneva, Geneva, Switzerland.
7
Service of Nephrology, Department of Medicine, Lausanne University Hospital and University of Lausanne, Switzerland.
8
Service of Clinical Pathology, Lausanne University Hospital and University of Lausanne, Switzerland.
9
Division of Nephrology, University Hospital Zurich, Zurich, Switzerland.
10
Institute for Nephrology and Dialysis, Cantonal Hospital Baden, Baden, Switzerland.
11
Department of Medicine, Cantonal Hospital Frauenfeld, Spital Thurgau AG, Frauenfeld, Switzerland.
12
Faculty of Medicine, University of Zurich, Zurich, Switzerland.
PMID:
38765571
PMCID:
PMC11101795
DOI:
10.1016/j.ekir.2024.01.028
No abstract available
Keywords:
COVAN; COVID-19; SARS-CoV-2; glomerular disease; glomerulonephritis.